BST-CarGel Overview

  • Status
  • Acquired/​Merged
  • Latest Deal Type
  • Asset Purch.
  • Financing Rounds
  • 1

BST-CarGel General Information

Description

First-line cartilage repair product. The product is used along with microfracture and other bone marrow stimulation techniques for the initial treatment of most sizes of focal cartilage tears.

Contact Information

Ownership Status
Acquired/Merged
Financing Status
Corporate Backed or Acquired
Primary Industry
Buildings and Property
Other Industries
Pharmaceuticals
Acquirer
Primary Office
  • 475 boulevard Armand-Frappier
  • Laval, Quebec H7V 4B3
  • Canada
Want detailed data on 3M+ companies?

What you see here scratches the surface

Request a free trial
Want to dig into this profile?

We’ll help you find what you need

Learn more

BST-CarGel Valuation & Funding

Deal Type Date Amount Valuation/
EBITDA
Post-Val Status Debt

This information is available in the PitchBook Platform. To explore BST-CarGel‘s full profile, request access.

Request a free trial

BST-CarGel Former Investors

Investor Name Investor Type Holding Investor Since Participating Rounds Contact Info

This information is available in the PitchBook Platform. To explore BST-CarGel‘s full profile, request access.

Request a free trial